Fernandez, Manuela .
HRN: 22-49-89 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/21/2023
01/28/2023
IV
2.25g
Q8H
Sepsis Sec To DM Foot, L
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Disseminated Systemic Infection Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes